Oligometastatic Disease Detection with ⁶⁸Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.

Auteurs : Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: Differences between tangential beam and VMAT.

Auteurs : Ahrouch I, Van Gestel D, Koshariuk O, Kirkove C, Desmet A, Philippson C, Reynaert N, De Caluwe A
Jaar : 2021
Journal : Radiother Oncol
Volume : 164
Pagina's : 282-288

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.

Auteurs : De Caluwe A, Buisseret L, Poortmans P, Van Gestel D, Salgado R, Sotiriou C, Larsimont D, Paesmans M, Craciun L, Drisis S, Vandekerckhove C, Reyal F, Veys I, Eiger D, Piccart-Gebhart M, Romano E, Ignatiadis M
Jaar : 2021
Journal : BMC Cancer
Volume : 21
Pagina's : 899

Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.

Auteurs : Dragan T, Duprez F, Van Gossum A, Gulyban A, Beauvois S, Digonnet A, Lalami Y, Van Gestel D
Jaar : 2021
Journal : BMC Cancer
Volume : 21
Pagina's : 656

Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question.

Auteurs : Van Houtte P, Moretti L, Charlier F, Roelandts M, Van Gestel D
Jaar : 2021
Journal : Transl Lung Cancer Res
Volume : 10
Pagina's : 1950-1959

Evaluation of the XVI dual registration tool for image-guided radiotherapy in prostate cancer.

Auteurs : Sousa F, Jourani Y, Van den Begin R, Otte FX, Ridai S, Desle M, Ferreira A, Ahmimed R, van Klink-de Goeij MCM, Van Gestel D
Jaar : 2021
Journal : Tech Innov Patient Support Radiat Oncol
Volume : 18
Pagina's : 22-28

Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literature.

Auteurs : Benkhaled S, Mané M, Jungels C, Shumelinsky F, de Saint-Aubain de Somerhausen N, Van Gestel D
Jaar : 2021
Journal : Cancer Treat Res Commun
Volume : 26
Pagina's : 100282

Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.

Auteurs : Mané M, Benkhaled S, Dragan T, Paesmans M, Beauvois S, Lalami Y, Szturz P, Gaye PM, Vermorken JB, Van Gestel D
Jaar : 2021
Journal : Oncologist
Volume : 26
Pagina's : e130-e141

Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.

Auteurs : Bouchart C, Trépant AL, Hein M, Van Gestel D, Demetter P
Jaar : 2020
Journal : Cancer Med
Volume : 9
Pagina's : 1069-1078

Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer.

Auteurs : Genot-Klastersky MT, Paesmans M, Ameye L, Kayumba A, Beauvois S, Dragan T, Van Gestel D, Lalami Y, Klastersky J
Jaar : 2020
Journal : Support Care Cancer
Volume : 28
Pagina's : 3015-3022

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity.

Auteurs : Szturz P, Van Laer C, Simon C, Van Gestel D, Bourhis J, Vermorken JB
Jaar : 2020
Journal : Front Oncol
Volume : 10
Pagina's : 688

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma.

Auteurs : Van Gestel D, Dragan T, Grégoire V, Evans M, Budach V
Jaar : 2020
Journal : Front Oncol
Volume : 10
Pagina's : 282

Monte Carlo dose calculations of shielding disks with different material combinations in intraoperative electron radiation therapy (IOERT).

Auteurs : Alhamada H, Simon S, Philippson C, Vandekerkhove C, Jourani Y, Pauly N, Van Gestel D, Reynaert N
Jaar : 2020
Journal : Cancer Radiother
Volume : 24
Pagina's : 128-134

Integration of the M6 Cyberknife in the Moderato Monte Carlo platform and prediction of beam parameters using machine learning.

Auteurs : Wagner A, Brou Boni K, Rault E, Crop F, Lacornerie T, Van Gestel D, Reynaert N
Jaar : 2020
Journal : Phys Med
Volume : 70
Pagina's : 123-132

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Auteurs : Bouchart C, Navez J, Closset J, Hendlisz A, Van Gestel D, Moretti L, Van Laethem JL
Jaar : 2020
Journal : Ther Adv Med Oncol
Volume : 12
Pagina's : 1758835920936093

Brachytherapy in Belgium in 2018. A national survey of the brachytherapy study group of the Belgian SocieTy for Radiotherapy and Oncology (BeSTRO).

Auteurs : Salembier C, De Hertogh O, Daisne JF, Palumbo S, Van Gestel D
Jaar : 2020
Journal : Radiother Oncol
Volume : 150
Pagina's : 245-252

Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients.

Auteurs : Dragan T, Beauvois S, Moreau M, Paesmans M, Vandekerkhove C, Cordier L, Van Gestel D
Jaar : 2019
Journal : Oral Oncol
Volume : 98
Pagina's : 132-140

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Auteurs : Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem G, Van Gestel D
Jaar : 2019
Journal : Cancers (Basel)
Volume : 11

Ossifying Fibromyxoid Tumor with Spinal Cord Compression and Epiduritis.

Auteurs : De Wandeler T, Van Gestel D, Jissendi Tchofo P
Jaar : 2019
Journal : J Belg Soc Radiol
Volume : 103
Pagina's : 18

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer.

Auteurs : Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Adelstein D, Van Gestel D, Vermorken JB
Jaar : 2019
Journal : Front Oncol
Volume : 9
Pagina's : 86